Clinical trial

An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for…

NCT00236990 · McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Industry · Completed

Key facts

NCT number NCT00236990
Title An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland
Official title A Double-Blind, Randomized, Placebo-Controlled Trial of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Prostatitis
Lead sponsor McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Industry
Collaborators Alza Corporation, DE, USA Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Prostatitis
Intervention type Drug
Interventions pentosan polysulfate sodium
Enrollment 283
Completion Sep 1, 2005
First posted Oct 12, 2005
Last update posted Jul 1, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies